Tag Archives: Obalon Therapeutics Inc

Northland Securities Sticks to Their Hold Rating for Obalon Therapeutics Inc (OBLN)

Northland Securities analyst Suraj Kalia maintained a Hold rating on Obalon Therapeutics Inc (OBLN – Research Report) today and set a price target of $1. The company’s shares closed yesterday at $0.66, close to its 52-week low of $0.37. Kalia

Northland Securities Keeps Their Hold Rating on Obalon Therapeutics Inc (OBLN)

In a report released today, Suraj Kalia from Northland Securities maintained a Hold rating on Obalon Therapeutics Inc (OBLN – Research Report), with a price target of $1. The company’s shares opened today at $0.59, close to its 52-week low

Northland Securities Maintains Their Hold Rating on Obalon Therapeutics Inc (OBLN)

Northland Securities analyst Suraj Kalia maintained a Hold rating on Obalon Therapeutics Inc (OBLN – Research Report) today and set a price target of $2. The company’s shares opened today at $2.29, close to its 52-week low of $1.46. Kalia

Obalon Therapeutics Inc (OBLN) Receives a Hold from Northland Securities

Northland Securities analyst Suraj Kalia maintained a Hold rating on Obalon Therapeutics Inc (NASDAQ: OBLN) yesterday and set a price target of $2.50. The company’s shares opened today at $3.44. Kalia said: “We are tweaking our PT to $2.50, but

Obalon Therapeutics Inc (OBLN) Receives a Buy from BTIG

In a report issued on September 10, Sean Lavin from BTIG maintained a Buy rating on Obalon Therapeutics Inc (NASDAQ: OBLN), with a price target of $3.50. The company’s shares closed yesterday at $3.38. According to TipRanks.com, Lavin is a

Stifel Nicolaus Maintains Their Hold Rating on Obalon Therapeutics Inc (OBLN)

Stifel Nicolaus analyst Rick Wise maintained a Hold rating on Obalon Therapeutics Inc (NASDAQ: OBLN) today and set a price target of $3.50. The company’s shares closed yesterday at $3.36. According to TipRanks.com, Wise is a 5-star analyst with an